Carlos Malvestutto, MD MPH

Assistant Professor
The Ohio State University Wexner Medical Center

Disclosure(s): Gilead Sciences: Advisor/Consultant; Viiv Healthcare: Advisor/Consultant

Poster(s):

• 446 - Hyperlactatemia and Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTI): Still present even with modern antiretroviral therapy (ART)
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 2213 - Increased Early Syphilis Detection and Treatment in an Urban Emergency Department During the COVID-19 Pandemic
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET